Table:
begin	end	state
1	34	cytoplasmic
35	59	transmembrane
60	85	non-cytoplasmic
86	105	transmembrane
106	116	cytoplasmic
117	138	transmembrane
139	143	non-cytoplasmic
144	166	transmembrane
167	177	cytoplasmic
178	201	transmembrane
202	220	non-cytoplasmic
221	241	transmembrane
242	271	cytoplasmic
272	298	transmembrane
299	309	non-cytoplasmic
310	329	transmembrane
330	335	cytoplasmic
336	358	transmembrane
359	364	non-cytoplasmic

Input:
>HSERO_RS21915
MSLASLEIAKAGRAQADATQVDPVRAYRRSMRRRLLFTVALLVLIIGAVVLDIATGPAGI
AVQDLLATLLHADAAPAGLRVVVWEFRLPTAVMALLVGMCLGLGGGEMQTVLDNPLASPY
TLGISAAAAFGAALAITFNWRFPALPAGMTVSACACAAALASVLVLERVARWRGGSTLGV
ILFGIALVYSFQALIMLLQFVASEEALQGIVFWTMGSLARASWTTVAILGLAFALVAPFS
LRDAWKLTALRLGEERAASFGIDMPRLRMLSLLRISVLAALSVSFVGTIGFVGLVAPHIA
RLLLGEDHRYYLPGSAMAGGLIISLASVASKTLLPGVLIPVGIVTSLVGIPLFLIIVLRR
LRRE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server